A Case Report of Gemcitabine-Induced Steatohepatitis Associated With Adjuvant Monotherapy for Pancreatic Adenocarcinoma

The Medicine Forum
doi 10.29046/tmf.018.1.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Thomas Jefferson University

Related search

Deoxycitidine Kinase Is Associated With Prolonged Survival After Adjuvant Gemcitabine for Resected Pancreatic Adenocarcinoma

Cancer
Cancer ResearchOncology
2010English

A Case of Drug-Induced Hemolytic Uremic Syndrome During Adjuvant Chemotherapy With Gemcitabine Hydrochloride After Resection of Pancreatic Cancer

Suizo
2010English

Pancreatic Adenocarcinoma-Associated Polymyositis Treated With Corticosteroids Along With Cancer Specific Treatment: Case Report

BMC Gastroenterology
MedicineGastroenterology
2011English

Neoadjuvant Treatment With Gemcitabine Plus Nab-Paclitaxel Versus Surgery First for Pancreatic Adenocarcinoma

HPB
HepatologyGastroenterology
2018English

Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study

British Journal of Cancer
Cancer ResearchOncology
2006English

Administration of Gemcitabine for Metastatic Adenocarcinoma During Pregnancy: A Case Report and Review of the Literature

AJP Reports
GynecologyChild HealthPediatricsPerinatologyObstetrics
2014English

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Adjuvant Chemotherapy With Gemcitabine and Long-Term Outcomes Among Patients With Resected Pancreatic Cancer

JAMA - Journal of the American Medical Association
Medicine
2013English

HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy